Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Infertility × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 211 Carcinoma, Intraductal, Noninfiltrating 18 Breast Carcinoma In Situ 15 Neoplasm Metastasis 11 Breast Neoplasms, Male 11 Neoplasms 10 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Prostatic Neoplasms 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Breast Cancer Female 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Astrocytoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Sexuality 1 Sarcoma 1 Risk Reduction Behavior 1 Recurrence 1

Interventions

Clomiphene 17 Metformin 12 Letrozole 7 cetrorelix 6 Triptorelin Pamoate 6 Menotropins 5 Inositol 5 Chorionic Gonadotropin 4 follitropin alfa 3 Sperm Injections, Intracytoplasmic 3 Folic Acid 3 ulipristal acetate 2 follitropin beta 2 Therapeutics 2 Psychiatric Rehabilitation 2 Medroxyprogesterone Acetate 2 Goserelin 2 Gonadotropins 2 Fertilization in Vitro 2 Dydrogesterone 2 Cyclophosphamide 2 testosterone undecanoate 1 Uterine Myomectomy 1 Urofollitropin 1 Thyrotropin 1 Thioctic Acid 1 Testosterone 1 Tamoxifen 1 Tablets 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011684 2025-05-08

TALES

University of California, San Francisco

Phase 3 Recruiting

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon ⚡